共 12 条
[1]
de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., Boni C., Cortes-Funes H., Cervantes A., Freyer G., Papamichael D., Le Bail N., Louvet C., Hendler D., de Braud F., Wilson C., Morvan F., Bonetti A., Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J Clin Oncol, 18, pp. 2938-2947, (2000)
[2]
Douillard J.Y., Siena S., Cassidy J., Tabernero J., Burkes R., Barugel M., Humblet Y., Bodoky G., Cunningham D., Jassem J., Rivera F., Kocakova I., Ruff P., Blasinska-Morawiec M., Smakal M., Canon J.L., Rother M., Oliner K.S., Wolf M., Gansert J., Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study, J Clin Onc
[3]
Gockel I., Dirksen K., Messow C.M., Junginger T., Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus, World J Gastroenterol, 12, pp. 3746-3750, (2006)
[4]
Hwang J.E., Kim H.N., Kim D.E., Choi H.J., Jung S.H., Shim H.J., Bae W.K., Hwang E.C., Cho S.H., Chung I.J., Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer, BMC Cancer, 11, (2011)
[5]
Chen Z., Shao Y., Fan M., Zhuang Q., Wang K., Cao W., Xu X., He X., Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma, Int J Clin Exp Pathol, 8, pp. 14893-14900, (2015)
[6]
Nozoe T., Kohno M., Iguchi T., Mori E., Maeda T., Matsukuma A., Ezaki T., The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma, Surg Today, 42, pp. 532-535, (2012)
[7]
Maeda K., Shibutani M., Otani H., Nagahara H., Sugano K., Ikeya T., Kubo N., Amano R., Kimura K., Muguruma K., Tanaka H., Hirakawa K., Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor, World J Surg, 38, pp. 1217-1222, (2014)
[8]
Hsu C.W., King T.M., Wang H.T., Wang J.H., Factors that influence survival in unresectable metastatic or locally advanced colorectal cancer, Int J Color Dis, 26, pp. 1559-1566, (2011)
[9]
Kishiki T., Masaki T., Matsuoka H., Kobayashi T., Suzuki Y., Abe N., Mori T., Sugiyama M., Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer, Am J Surg, 206, pp. 234-240, (2013)
[10]
La Torre M., Nigri G., Cavallini M., Mercantini P., Ziparo V., Ramacciato G., The Glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma, Ann Surg Oncol, 19, pp. 2917-2923, (2012)